India’s pharma sector is expanding at 8% CAGR, leading with 9% exports in 2024. As the largest generic medicine exporter, it supplies 20% of global demand and 60% of vaccines. Growth in biotech, mRNA, and gene therapies is driving innovation, while sustainability and digital transformation reshape its future as a global pharma powerhouse.